Nebulizer Market Forecasts to 2028 – Global Analysis By Type (Ultrasonic Nebulizer, Mesh Nebulizer and Compressed Jet Nebulizer), Portability (Portable Nebulizer and Tabletop Nebulizer), Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) and Other Applications), End User and By Geography
According to Stratistics MRC, the Global Nebulizer Market is accounted for $1.12 billion in 2022 and is expected to reach $1.80 billion by 2028 growing at a CAGR of 8.2% during the forecast period. A nebulizer is a medication delivery tool that facilitates the inhalation of medication in the form of a mist. These gadgets create a thin mist of liquid by forcing compressed air through it, which is then inhaled through a mouthpiece or mask. These devices are made to treat respiratory conditions such as COPD, asthma, and asthma cystic fibrosis.
According to an article published by Greater London Authority in July 2021, around 337,500 people in London suffered from asthma attacks, with poor air quality being the reason.
Market Dynamics:
Driver:
Increasing incidence of respiratory disorders
The frequency is constantly increasing in emerging countries, resulting in a high number of individuals suffering from respiratory illnesses. A rising number of individuals are receiving treatment as a result of various government initiatives to encourage early diagnosis and treatment. The acceptance of these devices has also been significantly influenced by the market's rising launch of new items, particularly nebulization devices. For instance, in India in 2020, Omron Healthcare unveiled the ""OMRON NE C106,"" a nebulizer that is affordable and suitable for all age groups.
Restraint:
Safety concerns
Concerns have been raised about the safety profile of breathing devices in terms of infection transfer. The potential of infection transmission from nebulizer tubing to the patient's lungs or from the devices' non-sterile chambers are two additional reasons that are restricting the usage of these devices that healthcare professionals prescribe. As a result, some centers have recently switched from employing nebulizers to metered dose inhalers (pMDI) with valved holding chambers as a result of these issues. Metered dosage inhalers are useful for treating asthma since they are compact, transportable, and simple to use.
Opportunity:
Growing demand for home healthcare devices
The rising expense of healthcare services and hospital stays has resulted in a preference for homecare settings for patient treatment. Patients are encouraged to receive care at home due to the rising costs of hospital stays for treating respiratory conditions such chronic obstructive pulmonary disease (COPD), asthma, and others. This factor increased the use of breathable medical equipment for at-home treatment. Thus, the marketing of respiratory care devices for home use by numerous healthcare organizations and the rising need for efficient inhaled drug delivery devices are likely to fuel the expansion of this market over the anticipated period.
Threat:
Cost and the increasing availability of alternate options for treatment
Cost and the expanding number of treatment alternatives are further factors that are limiting the segment's growth. Nebulizer demand is likely to experience competition as patients increasingly adopt alternative devices for treating respiratory conditions. Healthcare professionals are increasingly favoring inhalers, notably metered-dose inhalers, for the treatment of asthma. Patients are increasingly choosing inhalers over nebulizers due to the therapeutic and practical advantages of MDIs in treating asthma as well as the cheaper cost of these devices.
Covid-19 Impact
The emergence of the COVID-19 pandemic had a worldwide impact. Many individuals needed a home nebulizer during the pandemic to treat their respiratory issues. As the virus may linger in airborne droplets for 1-2 hours, the nebulizer should be placed in an area that minimizes exposure to non-infected patients in hospitals or healthcare facilities. As a result, the demand for nebulizers increased. Because this illness makes breathing difficult, the rising number of COVID cases has prompted a worldwide rush to buy nebulizers.
The mesh nebulizers segment is expected to be the largest during the forecast period
The mesh nebulizers segment is estimated to have a lucrative growth, due to the technologically enhanced compact size devices and reduced medication loss. The mesh nebulizer market is predicted to expand further, owing to greater patient acceptance, rapid treatment, mobility, and convenience. Further aiding in market penetration is the growing commercial acceptability of mesh nebulizers due to precise drug administration to the lung and decreased residual quantities.
The home healthcare segment is expected to have the highest CAGR during the forecast period
The home healthcare segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the rising price of hospital stays for the treatment of respiratory disorders including asthma, COPD, and others. Technological improvements in medication delivery devices have promoted the downsizing of nebulizers, making them appropriate for use in a home healthcare setting. The main drivers of the growth of the home healthcare market are the ageing population, the need to reduce healthcare expenses, and the increased prevalence of lung disorders.
Region with highest share:
North America is projected to hold the largest market share during the forecast period, owing to an increase in respiratory illnesses and government efforts such as favorable reimbursement scenarios, increased customer awareness, and well-established healthcare infrastructure an increased market share for North America is mostly due to the increasing prevalence of asthma and other chronic respiratory diseases in the area, as well as the growing use of advanced portable respiratory devices.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to the rising prevalence of respiratory illnesses is a result of the market's expansion in Europe, which is helping to drive up demand for these devices there. For instance, 1.1 million hospital admissions for respiratory diseases were reported in the UK in 2021, according to information released by GOV.UK. As a result, the increased prevalence of respiratory disorders throughout the region is contributing to the segment's rise.
Key players in the market
Some of the key players profiled in the Nebulizer Market include Beurer GmBH, PARI Respiratory Equipment, Inc., GE Healthcare, Koninklijke Philips N.V., Omron Corporation, DeVilbiss Healthcare LLC, Vectura Group Plc., Briggs Healthcare, Teleflex Medical, Inc., Novartis AG, OPKO Health Inc., Sensirion AG , Cohero Health, Inc., GSK Group of Companies
Key Developments:
In July 2021, PARI GmbH collaborated with TWT Digital Health (TWT) and developed the PARI Connect app. This app can be used to plan inhalations, take medications, or make doctor’s appointments and also enables the user to observe all the facts of their therapy. The app also communicates via Bluetooth with the eTrack controller, a control unit for PARI’s eFlow Technology nebulizer.
In October 2020, OMRON Healthcare, Inc. expanded the range of prescription-grade nebulizers. These systems are compact, quiet, and portable and provide greater ease to patients to manage asthma and chronic obstructive pulmonary disease (COPD).
In July 2020, OMRON Healthcare Inc., the leading Japanese player in home healthcare, announced the launch of OMRON NE C106. It is an addition to their compressor nebulizer portfolio. The company is continuously innovating in the area of respiratory medication delivery.
Types Covered:
• Ultrasonic Nebulizer
• Mesh Nebulizer
• Compressed Jet Nebulizer
Portabilities Covered:
• Portable Nebulizer
• Tabletop Nebulizer
Applications Covered:
• Asthma
• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Applications
End Users Covered:
• Emergency Centers
• Home Healthcare
• Hospitals and Clinics
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook